CHOP plus rituximab - Balancing facts and opinion.

被引：30

作者：

Cheson, BD ^{[1
]}

机构：

[1] NCI, Bethesda, MD 20892 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 346卷 / 04期

关键词：

D O I：

10.1056/NEJM200201243460411

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：280 / 282

页数：4

共 15 条

[1] Alas S, 2001, CANCER RES, V61, P5137
[2] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Coiffier, B
Lepage, E
Brière, J
Herbrecht, R
Tilly, H
Bouabdallah, R
Morel, P
Van den Neste, E
Salles, G
Gaulard, P
Reyes, F
Gisselbrecht, C
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) : 235 - 242
[3] Czuczman M, 1999, BLOOD, V94, p99A
[4] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
Czuczman, MS
Grillo-López, AJ
White, CA
Saleh, M
Gordon, L
LoBuglio, AF
Jonas, C
Klippenstein, D
Dallaire, B
Varns, C
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 268 - 276
[5] Czuczman MS, 2000, BLOOD, V96, p729A
[6] LONG-TERM FOLLOW-UP OF PATIENTS WITH LOW-GRADE MALIGNANT-LYMPHOMAS TREATED WITH DOXORUBICIN-BASED CHEMOTHERAPY OR CHEMOIMMUNOTHERAPY
DANA, BW
DAHLBERG, S
NATHWANI, BN
CHASE, E
COLTMAN, C
MILLER, TP
FISHER, RI
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) : 644 - 651
[7] COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA
FISHER, RI
GAYNOR, ER
DAHLBERG, S
OKEN, MM
GROGAN, TM
MIZE, EM
GLICK, JH
COLTMAN, CA
MILLER, TP
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) : 1002 - 1006
[8] Cancer statistics, 2001
Greenlee, RT
Hill-Harmon, MB
Murray, T
Thun, M
[J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) : 15 - 36
[9] Greenlee RT, 2001, CA-CANCER J CLIN, V51, P144
[10] Pivotal study of iodine I 131 Tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas
Kaminski, MS
Zelenetz, AD
Press, OW
Saleh, M
Leonard, J
Fehrenbacher, L
Lister, TA
Stagg, RJ
Tidmarsh, GF
Kroll, S
Wahl, RL
Knox, SJ
Vose, JM
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) : 3918 - 3928

← 1 2 →